CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Trinity Biotech PLC - ADR Company Snapshot
Trinity Biotech PLC operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Trinity Biotech PLC with three other pharmaceutical manufacturers in North America: Clovis Oncology Inc (2018 sales of $95.39 million of which 100% was Anti Cancer Medicines), Melinta Therapeutics Inc ($96.43 million of which 100% was Pharmaceutical Preparations), and Agios Pharmaceuticals Inc ($94.39 million of which 100% was Bio-Pharmaceutical).

Sales Analysis.
   
   
 
  Stock Performance Chart for Trinity Biotech PLC - ADR
 
  Stock Data: Recent Stock Performance:
  Current Price (10/18/2019): .80
(Figures in U.S. Dollars)
1 Week -15.9%   13 Weeks -41.6%  
4 Weeks -63.7%   52 Weeks -76.6%  
 
Trinity Biotech PLC - ADR Key Data:
  Ticker: TRIB Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2018 Sales 97,035,101
(Year Ending Jan 2019).
Employees: 575
  Currency: U.S. Dollars Market Cap: N/A
  Fiscal Yr Ends: December Shares Outstanding: N/A
  Share Type: Class A Ordinary Closely Held Shares: N/A
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.